Background: Depression, which is the most common psychological disorder among patients with end-stage renal disease (ESRD), is commonly associated with poor oral intake which can aggravate anemia and malnutrition in chronic dialysis patients. The objective of this study is to explore the association between depression and C-reactive protein (CRP), ferritin, serum albumin and hemoglobin/hematocrit in patients with chronic kidney disease (CKD) and ESRD. Methods: Sixty-eight patients on hemodialysis (HD), 47 patients on continuous ambulatory peritoneal dialysis (CAPD) and 26 patients with CKD on conservative management were enrolled in this study. All patients were evaluated for the presence of depression using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders-Clinician Version (SCID-CV). The severity of depression was evaluated by means of the Beck Depression Inventory (BDI). Serum CRP (nephelometric method), ferritin (immunometric method), albumin (bromcresol green technique), hemoglobin, and hematocrit levels were measured. Results: A total of 34 of 141 patients (24.1%) had depression. The mean BDI score was higher in depressive patients compared to nondepressive patients. In HD patients the frequency of depression and CRP and ferritin levels were higher than in other groups. Patients with depression had lower hemoglobin, hematocrit and serum albumin levels and higher CRP and ferritin levels than patients without depression. The BDI score showed a positive correlation with serum CRP and ferritin levels, but a negative correlation with the serum albumin level. Conclusions: We observed that CKD and ESRD patients with anemia, hypoalbuminemia and higher serum CRP and ferritin concentrations should be evaluated for depression after potential somatic causes have been eliminated.

Keywords:
Depression, C-reactive protein, Hypoalbuminemia, Chronic kidney disease, End-stage renal disease
1.
Kimmel PL: Psychosocial factors in dialysis patients. Kidney Int 2001;59:1599–1613.
2.
Finkelstein FO, Finkelstein SH: Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant 2000;15:1911–1913.
3.
Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993;4:12–27.
4.
Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Multiple measurements of depression predict mortality in longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57:2093–2098.
5.
Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK: Dialysis Outcomes and Practice Patterns Study (DOPPS): depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002;62:199–207.
6.
Blumenkrantz MJ: Nutrition; in Daurgidas JT, Ings TS (eds): Handbook of Dialysis, ed 2. Boston, Little, Brown, 1994, pp 374–400.
7.
Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999;55:1945–1951.
8.
Owen WF, Lowrie EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998;54:627–636.
9.
Cooper BA, Penne EL, Bartlett LH, Pollock CA: Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004;43:61–66.
10.
Okhuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohadhi H: C-reactive protein, lipoprotein(a), and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 2003;42:355–361.
11.
Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469–476.
12.
Kalender B, Mutlu B, Ersöz M, Kalkan A, Yılmaz A: The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. Int J Clin Pract 2002;56:505–508.
13.
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648–658.
14.
Owen WF, Lowrie EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998;54:627–636.
15.
Lowrie EG: Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis 1998;32(suppl 4):105–112.
16.
Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW: The acute phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000;58:346–352.
17.
Dantzer R: Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 2001;15:7–24.
18.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C: Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004;25:492–499.
19.
First MB, Spitzer RL, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, American Psychiatric Press, 1997.
20.
Corapcıoglu A, Aydemir O, Yıldız M, Esen Danacı A, Koroglu E: Turkish adaptation of Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Turk J Drug Treat 1999;12:33–36.
21.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571.
22.
Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100.
23.
Daurgidas JT: Chronic hemodialysis prescription: a urea kinetic approach; in Daurgidas JT, Ings TS (eds): Handbook of Dialysis, ed 2. Boston, Little, Brown, 1994, pp 92–120.
24.
Movilli E: Simplified approaches to calculate Kt/V. It’s time for agreement. Nephrol Dial Transplant 1996;11: 24–27.
25.
Cockroft DW, Gault MH, Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
26.
Danielski M, Ikizler A, McMonagle E, Kane JC, Pupim L, Morrow MD, Himmelfarb J: Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 2003;42:286–294.
27.
Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P: Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 2003;18:1042–1045.
28.
Stenvinkel P: The role of inflammation in the anemia of end-stage renal disease. Nephrol Dial Transplant 2001;16:36–40.
29.
Castenada C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS: Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004;43:607–616.
30.
Danner M, Kasl SV, Abramson JL, Vaccarino V: Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347–356.
31.
Ford DE, Erlinger TP: Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164:1010–1014.
32.
Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003;170:429–433.
33.
van West D, Maes M: Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuroendocrinol Lett 1999;20:11–17.
34.
Leonard BE: The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:767–780.
35.
Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, Kim HJ, Chae DW, Noh JW, Lee SK, Son BK: Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 2003;41:1037–1042.
36.
Watnick S, Kirwin P, Mahnensmith R, Concato J: The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003;41:105–110.
37.
Craven JL, Rodin GM, Littlefield C: The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1998;18:365–374.
38.
Hisli N: A study on validation of Beck Depression Inventory. Turk J Psychol 1998;6:118–122.
39.
Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO: Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003;42:350–354.
40.
O’Donnell K, Chung JY: The diagnosis of major depression in end-stage renal disease. Psychother Psychosom 1997;66:38–43.
41.
Njah M, Nasr M, Ben Dhia N: Anxiety and depression in the hemodialysis patient. Nephrologie 2001;22:353–357.
42.
Kim JA, Lee YK, Huh WS, Kim YG, Kim DJ, Oh HY, Kang SA, Kim Moon YH, Kim HW, Kim JH: Analysis of depression in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci 2002;17:790–794.
© 2006 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.